Dr Thomas Ford

  • Honorary Clinical Lecturer (School of Medicine, Dentistry & Nursing)

Publications

List by: Type | Date

Jump to: 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2008 | 2007
Number of items: 53.

2024

Bland, A., Chuah, E., Meere, W. and Ford, T. J. (2024) Targeted therapies for microvascular disease. Cardiology Clinics, 42(1), pp. 137-145. (doi: 10.1016/j.ccl.2023.07.002) (PMID:37949535)

2023

Ohashi, H. et al. (2023) Fractional flow reserve guided stent optimisation in focal and diffuse coronary artery disease. Diagnostics, 13(15), 2612. (doi: 10.3390/diagnostics13152612) (PMID:37568975) (PMCID:PMC10417445)

Collison, D. et al. (2023) Angina after percutaneous coronary intervention: patient and procedural predictors. Circulation: Cardiovascular Interventions, 16(4), e012511. (doi: 10.1161/CIRCINTERVENTIONS.122.012511) (PMID:36974680) (PMCID:PMC10101135)

Bland, A., Chuah, E., Meere, W. and Ford, T. J. (2023) Targeted therapies for microvascular disease. Interventional Cardiology Clinics, 12(1), pp. 131-139. (doi: 10.1016/j.iccl.2022.09.011) (PMID:36372457)

2022

Collet, C., Collison, D., Mizukami, T., McCartney, P., Sonck, J., Ford, T. , Munhoz, D., Berry, C. , De Bruyne, B. and Oldroyd, K. (2022) Differential improvement in angina and health-related quality of life after PCI in focal and diffuse coronary artery disease. JACC: Cardiovascular Interventions, 15(24), pp. 2506-2518. (doi: 10.1016/j.jcin.2022.09.048)

Ford, T. J. et al. (2022) Coronary artery perforations: Glasgow Natural History Study of Covered Stent Coronary Interventions (GNOCCI) Study. Journal of the American Heart Association, 11(19), e024492. (doi: 10.1161/JAHA.121.024492) (PMID:36129052) (PMCID:PMC9673697)

Ford, T. J. and Mikhail, P. (2022) Acetylcholine (re)challenge from diagnosis to targeted therapy. JACC: Cardiovascular Interventions, 15(1), pp. 76-79. (doi: 10.1016/j.jcin.2021.11.022) (PMID:34991827)

Mikhail, P. et al. (2022) Coronary perforation incidence, outcomes and temporal trends (COPIT): a systematic review and meta-analysis. Open Heart, 9, e002076. (doi: 10.1136/openhrt-2022-002076) (PMID:36270713) (PMCID:PMC9594565)

2021

Collison, D. et al. (2021) Post-stenting fractional flow reserve vs coronary angiography for optimization of percutaneous coronary intervention (TARGET-FFR). European Heart Journal, 42(45), pp. 4656-4668. (doi: 10.1093/eurheartj/ehab449) (PMID:34279606)

Morrow, A. et al. (2021) Rationale and design of the Medical Research Council Precision medicine with Zibotentan in microvascular angina (PRIZE) trial MRI sub-study. British Society of Cardiovascular Magnetic Resonance 2021 Annual Meeting, 12 October 2021. A2.1-A2. (doi: 10.1136/heartjnl-2021-BSCMR.3)

Rush, C. J. et al. (2021) Prevalence of coronary artery disease and coronary microvascular dysfunction in patients with heart failure with preserved ejection fraction. JAMA Cardiology, 6(10), pp. 1130-1143. (doi: 10.1001/jamacardio.2021.1825) (PMID:34160566) (PMCID:PMC8223134)

Heggie, R. et al. (2021) Stratified medicine using invasive coronary function testing in angina: a cost-effectiveness analysis of the British Heart Foundation CorMicA trial. International Journal of Cardiology, 337, pp. 44-51. (doi: 10.1016/j.ijcard.2021.05.016) (PMID:33992700)

Maznyczka, A. M. et al. (2021) Risk stratification guided by the index of microcirculatory resistance and left ventricular end-diastolic pressure in acute myocardial infarction. Circulation: Cardiovascular Interventions, 14(2), e009529. (doi: 10.1161/CIRCINTERVENTIONS.120.009529) (PMID:33591821)

2020

McCartney, P. J. et al. (2020) Low-dose intracoronary alteplase during primary percutaneous coronary intervention in patients with acute myocardial infarction: the T-TIME three-arm RCT. Efficacy and Mechanism Evaluation, 7(5), (doi: 10.3310/eme07050) (PMID:33175484)

Morrow, A. J. et al. (2020) Rationale and design of the Medical Research Council precision medicine with Zibotentan in microvascular angina (PRIZE) trial. American Heart Journal, 229, pp. 70-80. (doi: 10.1016/j.ahj.2020.07.007) (PMID:32942043)

Monjur, M. R., Said, C., Bamford, P., Parkinson, M., Szirt, R. and Ford, T. (2020) Ultrathin-strut biodegradable polymer versus durable polymer drug-eluting stents: a meta-analysis. Open Heart, 7, e001394. (doi: 10.1136/openhrt-2020-001394) (PMID:33046595) (PMCID:PMC7552849)

Ford, T. J. et al. (2020) Genetic dysregulation of endothelin-1 is implicated in coronary microvascular dysfunction. European Heart Journal, 41(34), pp. 3239-3252. (doi: 10.1093/eurheartj/ehz915) (PMID:31972008) (PMCID:PMC7557475)

Ford, T. J. et al. (2020) Assessment of vascular dysfunction in patients without obstructive coronary artery disease: why, how and when. JACC: Cardiovascular Interventions, 13(16), pp. 1847-1864. (doi: 10.1016/j.jcin.2020.05.052) (PMID:32819476) (PMCID:PMC7447977)

Fong, L. C. W., Ford, T. J. , da Costa, B. R., Jüni, P. and Berry, C. (2020) Bias and loss to follow-up in cardiovascular randomized trials: a systematic review. Journal of the American Heart Association, 9(14), e015361. (doi: 10.1161/JAHA.119.015361) (PMID:32646264) (PMCID:PMC7660731)

Hennigan, B. et al. (2020) Percutaneous coronary intervention versus medical therapy in patients with angina and grey-zone fractional flow reserve values: a randomised clinical trial. Heart, 106(10), pp. 714-715. (doi: 10.1136/heartjnl-2019-316075) (PMID:32114516) (PMCID:PMC7229900)

Ford, T. J. and Berry, C. (2020) Angina: contemporary diagnosis and management. Heart, 106(5), pp. 387-398. (doi: 10.1136/heartjnl-2018-314661) (PMID:2054665) (PMCID:PMC7035719)

Sidik, N. P. et al. (2020) Rationale and design of the British Heart Foundation (BHF) Coronary Microvascular Function and CT Coronary Angiogram (CorCTCA) study. American Heart Journal, 221, pp. 48-59. (doi: 10.1016/j.ahj.2019.11.015) (PMID:31911341) (PMCID:PMC7029345)

Ford, T. J. et al. (2020) Sex differences in procedural and clinical outcomes following rotational atherectomy. Catheterization and Cardiovascular Interventions, 95(2), pp. 232-241. (doi: 10.1002/ccd.28373) (PMID:31264314) (PMCID:PMC7027486)

Maznyczka, A. M. et al. (2020) One-year outcomes after low-dose intracoronary alteplase during primary percutaneous coronary intervention. The T-TIME randomized trial. Circulation: Cardiovascular Interventions, 13(2), e008855. (doi: 10.1161/CIRCINTERVENTIONS.119.008855) (PMID:32069113)

Ford, T. J. et al. (2020) 1-year outcomes of angina management guided by invasive coronary function testing (CorMicA). JACC: Cardiovascular Interventions, 13(1), pp. 33-45. (doi: 10.1016/j.jcin.2019.11.001) (PMID:31709984)

McCartney, P. J. et al. (2020) Low-dose alteplase during primary percutaneous coronary intervention according to ischemic time. Journal of the American College of Cardiology, 75(12), pp. 1406-1421. (doi: 10.1016/j.jacc.2020.01.041) (PMID:32216909) (PMCID:PMC7109518)

2019

Adamson, C., Rocchiccioli, P., Brogan, R., Berry, C. and Ford, T. J. (2019) Post-operative myocardial infarction following aortic root surgery with coronary reimplantation: a case series treated with percutaneous coronary intervention. European Heart Journal: Case Reports, 3(4), pp. 1-6. (doi: 10.1093/ehjcr/ytz181) (PMID:32123801) (PMCID:PMC7042144)

Ford, T. J. et al. (2019) Ischemia and no obstructive coronary artery disease: prevalence and correlates of coronary vasomotion disorders. Circulation: Cardiovascular Interventions, 12(12), e008126. (doi: 10.1161/CIRCINTERVENTIONS.119.008126) (PMID:31833416) (PMCID:PMC6924940)

Ubaid, S. et al. (2019) Cangrelor versus ticagrelor in patients treated with primary percutaneous coronary intervention: impact on platelet activity, myocardial microvascular function and infarct size: a randomized controlled trial. Thrombosis and Haemostasis, 119(07), pp. 1171-1181. (doi: 10.1055/s-0039-1688789) (PMID:31129911)

Ford, T. and Berry, C. (2019) How to diagnose and manage angina without obstructive coronary artery disease: Lessons from the British Heart Foundation CorMicA trial. Interventional Cardiology Review, 14(2), pp. 76-82. (doi: 10.15420/icr.2019.04.R1) (PMID:31178933) (PMCID:PMC6545998)

Berry, C. , Sidik, N., Pereira, A. C., Ford, T. J. , Touyz, R. M. , Kaski, J.-C. and Hainsworth, A. H. (2019) Small-vessel disease in the heart and brain: current knowledge, unmet therapeutic need, and future directions. Journal of the American Heart Association, 8(3), e011104. (doi: 10.1161/JAHA.118.011104) (PMID:30712442) (PMCID:PMC6405580)

Ford, T. , Corcoran, D., Sidik, N., Oldroyd, K. G., Rocchiccioli, P., McEntegart, M. and Berry, C. (2019) MINOCA: Requirement for definitive diagnostic work-up. Heart, Lung and Circulation, 28(2), e4-e6. (doi: 10.1016/j.hlc.2018.04.001) (PMID:30654950)

McCartney, P. J. et al. (2019) Effect of low-dose intracoronary alteplase during primary percutaneous coronary intervention on microvascular obstruction in patients with acute myocardial infarction: a randomized clinical trial. JAMA: Journal of the American Medical Association, 321(1), pp. 56-68. (doi: 10.1001/jama.2018.19802) (PMID:30620371) (PMCID:PMC6583564)

Corcoran, D., Ford, T. J. and Berry, C. (2019) Stable coronary syndromes. In: Touyz, R. M. and Delles, C. (eds.) Textbook of Vascular Medicine. Springer: Cham, pp. 373-381. ISBN 9783030164805 (doi: 10.1007/978-3-030-16481-2_35)

2018

Ford, T. J. et al. (2018) Stratified medical therapy using invasive coronary function testing in angina: CorMicA trial. Journal of the American College of Cardiology, 72(23 PtA), pp. 2841-2855. (doi: 10.1016/j.jacc.2018.09.006) (PMID:30266608)

Ford, T. J. , McEntegart, M., Berry, C. and Oldroyd, K. G. (2018) Arterial access for invasive coronary angiography: the 'left backhander'. Heart, Lung and Circulation, 27(8), e98-e99. (doi: 10.1016/j.hlc.2018.02.021) (PMID:29581039)

Ford, T. J. , Corcoran, D., Sidik, N., McEntegart, M. and Berry, C. (2018) Coronary microvascular dysfunction: Assessment of both structure and function. Journal of the American College of Cardiology, 72(5), pp. 584-586. (doi: 10.1016/j.jacc.2018.03.545) (PMID:30049318)

Ford, T. J. et al. (2018) Rationale and design of the British Heart Foundation (BHF) Coronary Microvascular Angina (CorMicA) stratified medicine clinical trial. American Heart Journal, 201, pp. 86-94. (doi: 10.1016/j.ahj.2018.03.010) (PMID:29803987) (PMCID:PMC6018570)

Ford, T. J. (2018) Coronary physiology and prognosis – What does pressure-bounded coronary flow reserve add? International Journal of Cardiology, 261, pp. 32-34. (doi: 10.1016/j.ijcard.2018.03.032) (PMID:29657052)

Ford, T. J. , McCartney, P., Corcoran, D., Collison, D., Hennigan, B., McEntegart, M., Hildick-Smith, D., Oldroyd, K. G. and Berry, C. (2018) Single versus two-stent strategies for coronary bifurcation lesions: a systematic review and meta-analysis of randomized trials with long-term follow-up. Journal of the American Heart Association, 7(11), e008730. (doi: 10.1161/JAHA.118.008730) (PMID:29802145) (PMCID:PMC6015365)

Corcoran, D. et al. (2018) Rationale and design of the Coronary Microvascular Angina Cardiac Magnetic Resonance imaging (CorCMR) diagnostic study: the CorMicA CMR sub-study. Open Heart, 5(2), e000924. (doi: 10.1136/openhrt-2018-000924) (PMID:30687508) (PMCID:PMC6326326)

Ford, T. J. , Nguyen, K., Brassil, J., Kushwaha, V., Friedman, D., Allan, R., Pitney, M. and Jepson, N. (2018) Balloon aortic valvuloplasty in the transcatheter valve era: single centre indications and early safety data in a high risk population. Heart, Lung and Circulation, 27(5), pp. 595-600. (doi: 10.1016/j.hlc.2017.05.128) (PMID:28688833)

Weisbord, S. D. et al. (2018) Outcomes after angiography with sodium bicarbonate and acetylcysteine. New England Journal of Medicine, 378(7), pp. 603-614. (doi: 10.1056/NEJMoa1710933) (PMID:29130810)

Ford, T. J. and Rocchiccioli, P. (2018) A keen eye for risk. British Medical Journal, 360, j5884. (doi: 10.1136/bmj.j5884) (PMID:29419393)

Ford, T. J. , Corcoran, D. and Berry, C. (2018) Stable coronary syndromes: pathophysiology, diagnostic advances and therapeutic need. Heart, 104(4), pp. 284-292. (doi: 10.1136/heartjnl-2017-311446) (PMID:29030424) (PMCID:PMC5861393)

2017

Ford, T. J. , Berry, C. , De Bruyne, B., Yong, A. C.S., Barlis, P., Fearon, W. F. and Ng, M. K.C. (2017) Physiological predictors of acute coronary syndromes: emerging insights from the plaque to the vulnerable patient. JACC: Cardiovascular Interventions, 10(24), pp. 2539-2547. (doi: 10.1016/j.jcin.2017.08.059) (PMID:29268883)

Ford, T. J. , Corcoran, D. and Berry, C. (2017) Coronary artery disease: physiology and prognosis. European Heart Journal, 38(25), pp. 1990-1992. (doi: 10.1093/eurheartj/ehx226) (PMID:28549103) (PMCID:PMC5837611)

2016

Ford, T. and Rees, D. (2016) Patent ductus arteriosus illuminating an old eponym. British Medical Journal, 353, i2182. (doi: 10.1136/bmj.i2182) (PMID:27154278)

2015

Robaei, D., Ford, T. and Ooi, S.-Y. (2015) Ankyrin-B syndrome: a case of sinus node dysfunction, atrial fibrillation and prolonged QT in a young adult. Heart, Lung and Circulation, 24(2), e31-e34. (doi: 10.1016/j.hlc.2014.09.013) (PMID:25456501)

2014

Ford, T. J. , Fong, M.W., Cheah, B.C. and Alexopolous, C. (2014) Pulmonary hypertension and hepatic encephalopathy: lethal complications of Rendu-Osler-Weber disease. Journal of the Royal College of Physicians of Edinburgh, 44(2), pp. 126-129. (doi: 10.4997/JRCPE.2014.207) (PMID:24999773)

2013

Ford, T. J. , Cranney, G. and Li, A. (2013) An ECG that changed in a febrile patient. British Medical Journal, 346, f585-f585. (doi: 10.1136/bmj.f585) (PMID:23390225)

2008

Ford, T. J. and Dillon, J. F. (2008) Minocycline hepatitis. European Journal of Gastroenterology and Hepatology, 20(8), pp. 796-799. (doi: 10.1097/MEG.0b013e3282f493c5) (PMID:18617786)

2007

Camilleri, M., Vazquez-Roque, M.I., Burton, D., Ford, T. , McKinzie, S., Zinsmeister, A.R. and Druzgala, P. (2007) Pharmacodynamic effects of a novel prokinetic 5-HT4receptor agonist, ATI-7505, in humans. Neurogastroenterology and Motility, 19(1), pp. 30-38. (doi: 10.1111/j.1365-2982.2006.00865.x) (PMID:17187586)

This list was generated on Sat Apr 20 03:26:12 2024 BST.
Number of items: 53.

Articles

Bland, A., Chuah, E., Meere, W. and Ford, T. J. (2024) Targeted therapies for microvascular disease. Cardiology Clinics, 42(1), pp. 137-145. (doi: 10.1016/j.ccl.2023.07.002) (PMID:37949535)

Ohashi, H. et al. (2023) Fractional flow reserve guided stent optimisation in focal and diffuse coronary artery disease. Diagnostics, 13(15), 2612. (doi: 10.3390/diagnostics13152612) (PMID:37568975) (PMCID:PMC10417445)

Collison, D. et al. (2023) Angina after percutaneous coronary intervention: patient and procedural predictors. Circulation: Cardiovascular Interventions, 16(4), e012511. (doi: 10.1161/CIRCINTERVENTIONS.122.012511) (PMID:36974680) (PMCID:PMC10101135)

Bland, A., Chuah, E., Meere, W. and Ford, T. J. (2023) Targeted therapies for microvascular disease. Interventional Cardiology Clinics, 12(1), pp. 131-139. (doi: 10.1016/j.iccl.2022.09.011) (PMID:36372457)

Collet, C., Collison, D., Mizukami, T., McCartney, P., Sonck, J., Ford, T. , Munhoz, D., Berry, C. , De Bruyne, B. and Oldroyd, K. (2022) Differential improvement in angina and health-related quality of life after PCI in focal and diffuse coronary artery disease. JACC: Cardiovascular Interventions, 15(24), pp. 2506-2518. (doi: 10.1016/j.jcin.2022.09.048)

Ford, T. J. et al. (2022) Coronary artery perforations: Glasgow Natural History Study of Covered Stent Coronary Interventions (GNOCCI) Study. Journal of the American Heart Association, 11(19), e024492. (doi: 10.1161/JAHA.121.024492) (PMID:36129052) (PMCID:PMC9673697)

Ford, T. J. and Mikhail, P. (2022) Acetylcholine (re)challenge from diagnosis to targeted therapy. JACC: Cardiovascular Interventions, 15(1), pp. 76-79. (doi: 10.1016/j.jcin.2021.11.022) (PMID:34991827)

Mikhail, P. et al. (2022) Coronary perforation incidence, outcomes and temporal trends (COPIT): a systematic review and meta-analysis. Open Heart, 9, e002076. (doi: 10.1136/openhrt-2022-002076) (PMID:36270713) (PMCID:PMC9594565)

Collison, D. et al. (2021) Post-stenting fractional flow reserve vs coronary angiography for optimization of percutaneous coronary intervention (TARGET-FFR). European Heart Journal, 42(45), pp. 4656-4668. (doi: 10.1093/eurheartj/ehab449) (PMID:34279606)

Rush, C. J. et al. (2021) Prevalence of coronary artery disease and coronary microvascular dysfunction in patients with heart failure with preserved ejection fraction. JAMA Cardiology, 6(10), pp. 1130-1143. (doi: 10.1001/jamacardio.2021.1825) (PMID:34160566) (PMCID:PMC8223134)

Heggie, R. et al. (2021) Stratified medicine using invasive coronary function testing in angina: a cost-effectiveness analysis of the British Heart Foundation CorMicA trial. International Journal of Cardiology, 337, pp. 44-51. (doi: 10.1016/j.ijcard.2021.05.016) (PMID:33992700)

Maznyczka, A. M. et al. (2021) Risk stratification guided by the index of microcirculatory resistance and left ventricular end-diastolic pressure in acute myocardial infarction. Circulation: Cardiovascular Interventions, 14(2), e009529. (doi: 10.1161/CIRCINTERVENTIONS.120.009529) (PMID:33591821)

McCartney, P. J. et al. (2020) Low-dose intracoronary alteplase during primary percutaneous coronary intervention in patients with acute myocardial infarction: the T-TIME three-arm RCT. Efficacy and Mechanism Evaluation, 7(5), (doi: 10.3310/eme07050) (PMID:33175484)

Morrow, A. J. et al. (2020) Rationale and design of the Medical Research Council precision medicine with Zibotentan in microvascular angina (PRIZE) trial. American Heart Journal, 229, pp. 70-80. (doi: 10.1016/j.ahj.2020.07.007) (PMID:32942043)

Monjur, M. R., Said, C., Bamford, P., Parkinson, M., Szirt, R. and Ford, T. (2020) Ultrathin-strut biodegradable polymer versus durable polymer drug-eluting stents: a meta-analysis. Open Heart, 7, e001394. (doi: 10.1136/openhrt-2020-001394) (PMID:33046595) (PMCID:PMC7552849)

Ford, T. J. et al. (2020) Genetic dysregulation of endothelin-1 is implicated in coronary microvascular dysfunction. European Heart Journal, 41(34), pp. 3239-3252. (doi: 10.1093/eurheartj/ehz915) (PMID:31972008) (PMCID:PMC7557475)

Ford, T. J. et al. (2020) Assessment of vascular dysfunction in patients without obstructive coronary artery disease: why, how and when. JACC: Cardiovascular Interventions, 13(16), pp. 1847-1864. (doi: 10.1016/j.jcin.2020.05.052) (PMID:32819476) (PMCID:PMC7447977)

Fong, L. C. W., Ford, T. J. , da Costa, B. R., Jüni, P. and Berry, C. (2020) Bias and loss to follow-up in cardiovascular randomized trials: a systematic review. Journal of the American Heart Association, 9(14), e015361. (doi: 10.1161/JAHA.119.015361) (PMID:32646264) (PMCID:PMC7660731)

Hennigan, B. et al. (2020) Percutaneous coronary intervention versus medical therapy in patients with angina and grey-zone fractional flow reserve values: a randomised clinical trial. Heart, 106(10), pp. 714-715. (doi: 10.1136/heartjnl-2019-316075) (PMID:32114516) (PMCID:PMC7229900)

Ford, T. J. and Berry, C. (2020) Angina: contemporary diagnosis and management. Heart, 106(5), pp. 387-398. (doi: 10.1136/heartjnl-2018-314661) (PMID:2054665) (PMCID:PMC7035719)

Sidik, N. P. et al. (2020) Rationale and design of the British Heart Foundation (BHF) Coronary Microvascular Function and CT Coronary Angiogram (CorCTCA) study. American Heart Journal, 221, pp. 48-59. (doi: 10.1016/j.ahj.2019.11.015) (PMID:31911341) (PMCID:PMC7029345)

Ford, T. J. et al. (2020) Sex differences in procedural and clinical outcomes following rotational atherectomy. Catheterization and Cardiovascular Interventions, 95(2), pp. 232-241. (doi: 10.1002/ccd.28373) (PMID:31264314) (PMCID:PMC7027486)

Maznyczka, A. M. et al. (2020) One-year outcomes after low-dose intracoronary alteplase during primary percutaneous coronary intervention. The T-TIME randomized trial. Circulation: Cardiovascular Interventions, 13(2), e008855. (doi: 10.1161/CIRCINTERVENTIONS.119.008855) (PMID:32069113)

Ford, T. J. et al. (2020) 1-year outcomes of angina management guided by invasive coronary function testing (CorMicA). JACC: Cardiovascular Interventions, 13(1), pp. 33-45. (doi: 10.1016/j.jcin.2019.11.001) (PMID:31709984)

McCartney, P. J. et al. (2020) Low-dose alteplase during primary percutaneous coronary intervention according to ischemic time. Journal of the American College of Cardiology, 75(12), pp. 1406-1421. (doi: 10.1016/j.jacc.2020.01.041) (PMID:32216909) (PMCID:PMC7109518)

Adamson, C., Rocchiccioli, P., Brogan, R., Berry, C. and Ford, T. J. (2019) Post-operative myocardial infarction following aortic root surgery with coronary reimplantation: a case series treated with percutaneous coronary intervention. European Heart Journal: Case Reports, 3(4), pp. 1-6. (doi: 10.1093/ehjcr/ytz181) (PMID:32123801) (PMCID:PMC7042144)

Ford, T. J. et al. (2019) Ischemia and no obstructive coronary artery disease: prevalence and correlates of coronary vasomotion disorders. Circulation: Cardiovascular Interventions, 12(12), e008126. (doi: 10.1161/CIRCINTERVENTIONS.119.008126) (PMID:31833416) (PMCID:PMC6924940)

Ubaid, S. et al. (2019) Cangrelor versus ticagrelor in patients treated with primary percutaneous coronary intervention: impact on platelet activity, myocardial microvascular function and infarct size: a randomized controlled trial. Thrombosis and Haemostasis, 119(07), pp. 1171-1181. (doi: 10.1055/s-0039-1688789) (PMID:31129911)

Ford, T. and Berry, C. (2019) How to diagnose and manage angina without obstructive coronary artery disease: Lessons from the British Heart Foundation CorMicA trial. Interventional Cardiology Review, 14(2), pp. 76-82. (doi: 10.15420/icr.2019.04.R1) (PMID:31178933) (PMCID:PMC6545998)

Berry, C. , Sidik, N., Pereira, A. C., Ford, T. J. , Touyz, R. M. , Kaski, J.-C. and Hainsworth, A. H. (2019) Small-vessel disease in the heart and brain: current knowledge, unmet therapeutic need, and future directions. Journal of the American Heart Association, 8(3), e011104. (doi: 10.1161/JAHA.118.011104) (PMID:30712442) (PMCID:PMC6405580)

Ford, T. , Corcoran, D., Sidik, N., Oldroyd, K. G., Rocchiccioli, P., McEntegart, M. and Berry, C. (2019) MINOCA: Requirement for definitive diagnostic work-up. Heart, Lung and Circulation, 28(2), e4-e6. (doi: 10.1016/j.hlc.2018.04.001) (PMID:30654950)

McCartney, P. J. et al. (2019) Effect of low-dose intracoronary alteplase during primary percutaneous coronary intervention on microvascular obstruction in patients with acute myocardial infarction: a randomized clinical trial. JAMA: Journal of the American Medical Association, 321(1), pp. 56-68. (doi: 10.1001/jama.2018.19802) (PMID:30620371) (PMCID:PMC6583564)

Ford, T. J. et al. (2018) Stratified medical therapy using invasive coronary function testing in angina: CorMicA trial. Journal of the American College of Cardiology, 72(23 PtA), pp. 2841-2855. (doi: 10.1016/j.jacc.2018.09.006) (PMID:30266608)

Ford, T. J. , McEntegart, M., Berry, C. and Oldroyd, K. G. (2018) Arterial access for invasive coronary angiography: the 'left backhander'. Heart, Lung and Circulation, 27(8), e98-e99. (doi: 10.1016/j.hlc.2018.02.021) (PMID:29581039)

Ford, T. J. , Corcoran, D., Sidik, N., McEntegart, M. and Berry, C. (2018) Coronary microvascular dysfunction: Assessment of both structure and function. Journal of the American College of Cardiology, 72(5), pp. 584-586. (doi: 10.1016/j.jacc.2018.03.545) (PMID:30049318)

Ford, T. J. et al. (2018) Rationale and design of the British Heart Foundation (BHF) Coronary Microvascular Angina (CorMicA) stratified medicine clinical trial. American Heart Journal, 201, pp. 86-94. (doi: 10.1016/j.ahj.2018.03.010) (PMID:29803987) (PMCID:PMC6018570)

Ford, T. J. (2018) Coronary physiology and prognosis – What does pressure-bounded coronary flow reserve add? International Journal of Cardiology, 261, pp. 32-34. (doi: 10.1016/j.ijcard.2018.03.032) (PMID:29657052)

Ford, T. J. , McCartney, P., Corcoran, D., Collison, D., Hennigan, B., McEntegart, M., Hildick-Smith, D., Oldroyd, K. G. and Berry, C. (2018) Single versus two-stent strategies for coronary bifurcation lesions: a systematic review and meta-analysis of randomized trials with long-term follow-up. Journal of the American Heart Association, 7(11), e008730. (doi: 10.1161/JAHA.118.008730) (PMID:29802145) (PMCID:PMC6015365)

Corcoran, D. et al. (2018) Rationale and design of the Coronary Microvascular Angina Cardiac Magnetic Resonance imaging (CorCMR) diagnostic study: the CorMicA CMR sub-study. Open Heart, 5(2), e000924. (doi: 10.1136/openhrt-2018-000924) (PMID:30687508) (PMCID:PMC6326326)

Ford, T. J. , Nguyen, K., Brassil, J., Kushwaha, V., Friedman, D., Allan, R., Pitney, M. and Jepson, N. (2018) Balloon aortic valvuloplasty in the transcatheter valve era: single centre indications and early safety data in a high risk population. Heart, Lung and Circulation, 27(5), pp. 595-600. (doi: 10.1016/j.hlc.2017.05.128) (PMID:28688833)

Weisbord, S. D. et al. (2018) Outcomes after angiography with sodium bicarbonate and acetylcysteine. New England Journal of Medicine, 378(7), pp. 603-614. (doi: 10.1056/NEJMoa1710933) (PMID:29130810)

Ford, T. J. and Rocchiccioli, P. (2018) A keen eye for risk. British Medical Journal, 360, j5884. (doi: 10.1136/bmj.j5884) (PMID:29419393)

Ford, T. J. , Corcoran, D. and Berry, C. (2018) Stable coronary syndromes: pathophysiology, diagnostic advances and therapeutic need. Heart, 104(4), pp. 284-292. (doi: 10.1136/heartjnl-2017-311446) (PMID:29030424) (PMCID:PMC5861393)

Ford, T. J. , Berry, C. , De Bruyne, B., Yong, A. C.S., Barlis, P., Fearon, W. F. and Ng, M. K.C. (2017) Physiological predictors of acute coronary syndromes: emerging insights from the plaque to the vulnerable patient. JACC: Cardiovascular Interventions, 10(24), pp. 2539-2547. (doi: 10.1016/j.jcin.2017.08.059) (PMID:29268883)

Ford, T. J. , Corcoran, D. and Berry, C. (2017) Coronary artery disease: physiology and prognosis. European Heart Journal, 38(25), pp. 1990-1992. (doi: 10.1093/eurheartj/ehx226) (PMID:28549103) (PMCID:PMC5837611)

Ford, T. and Rees, D. (2016) Patent ductus arteriosus illuminating an old eponym. British Medical Journal, 353, i2182. (doi: 10.1136/bmj.i2182) (PMID:27154278)

Robaei, D., Ford, T. and Ooi, S.-Y. (2015) Ankyrin-B syndrome: a case of sinus node dysfunction, atrial fibrillation and prolonged QT in a young adult. Heart, Lung and Circulation, 24(2), e31-e34. (doi: 10.1016/j.hlc.2014.09.013) (PMID:25456501)

Ford, T. J. , Fong, M.W., Cheah, B.C. and Alexopolous, C. (2014) Pulmonary hypertension and hepatic encephalopathy: lethal complications of Rendu-Osler-Weber disease. Journal of the Royal College of Physicians of Edinburgh, 44(2), pp. 126-129. (doi: 10.4997/JRCPE.2014.207) (PMID:24999773)

Ford, T. J. , Cranney, G. and Li, A. (2013) An ECG that changed in a febrile patient. British Medical Journal, 346, f585-f585. (doi: 10.1136/bmj.f585) (PMID:23390225)

Ford, T. J. and Dillon, J. F. (2008) Minocycline hepatitis. European Journal of Gastroenterology and Hepatology, 20(8), pp. 796-799. (doi: 10.1097/MEG.0b013e3282f493c5) (PMID:18617786)

Camilleri, M., Vazquez-Roque, M.I., Burton, D., Ford, T. , McKinzie, S., Zinsmeister, A.R. and Druzgala, P. (2007) Pharmacodynamic effects of a novel prokinetic 5-HT4receptor agonist, ATI-7505, in humans. Neurogastroenterology and Motility, 19(1), pp. 30-38. (doi: 10.1111/j.1365-2982.2006.00865.x) (PMID:17187586)

Book Sections

Corcoran, D., Ford, T. J. and Berry, C. (2019) Stable coronary syndromes. In: Touyz, R. M. and Delles, C. (eds.) Textbook of Vascular Medicine. Springer: Cham, pp. 373-381. ISBN 9783030164805 (doi: 10.1007/978-3-030-16481-2_35)

Conference or Workshop Item

Morrow, A. et al. (2021) Rationale and design of the Medical Research Council Precision medicine with Zibotentan in microvascular angina (PRIZE) trial MRI sub-study. British Society of Cardiovascular Magnetic Resonance 2021 Annual Meeting, 12 October 2021. A2.1-A2. (doi: 10.1136/heartjnl-2021-BSCMR.3)

This list was generated on Sun Apr 21 06:47:43 2024 BST.